Hudson Value Partners LLC Sells 114 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hudson Value Partners LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 987 shares of the healthcare conglomerate’s stock after selling 114 shares during the quarter. Hudson Value Partners LLC’s holdings in UnitedHealth Group were worth $503,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. International Assets Investment Management LLC boosted its stake in UnitedHealth Group by 1.9% during the fourth quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock valued at $2,352,000 after buying an additional 85 shares during the last quarter. GUNN & Co INVESTMENT MANAGEMENT INC. grew its holdings in shares of UnitedHealth Group by 1,337.3% in the fourth quarter. GUNN & Co INVESTMENT MANAGEMENT INC. now owns 97,679 shares of the healthcare conglomerate’s stock valued at $51,425,000 after purchasing an additional 90,883 shares in the last quarter. Mather Group LLC. increased its position in UnitedHealth Group by 6.4% in the fourth quarter. Mather Group LLC. now owns 5,193 shares of the healthcare conglomerate’s stock worth $2,734,000 after purchasing an additional 313 shares during the last quarter. Van ECK Associates Corp grew its stake in shares of UnitedHealth Group by 6.8% in the 4th quarter. Van ECK Associates Corp now owns 143,228 shares of the healthcare conglomerate’s stock worth $75,405,000 after buying an additional 9,159 shares in the last quarter. Finally, Duff & Phelps Investment Management Co. raised its position in shares of UnitedHealth Group by 0.8% during the 4th quarter. Duff & Phelps Investment Management Co. now owns 10,323 shares of the healthcare conglomerate’s stock valued at $5,435,000 after buying an additional 80 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.2 %

Shares of NYSE UNH traded down $1.43 during midday trading on Friday, reaching $590.14. 2,944,699 shares of the company’s stock traded hands, compared to its average volume of 4,101,315. The stock’s 50 day simple moving average is $546.21 and its 200-day simple moving average is $511.95. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market cap of $544.95 billion, a price-to-earnings ratio of 36.07, a P/E/G ratio of 1.63 and a beta of 0.59. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $593.26.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period in the previous year, the company posted $6.14 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s payout ratio is 51.34%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. TD Cowen raised their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Barclays raised their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Argus increased their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.